Hims & Hers Health is trading 8.3% up today at €30.70 as a broader rally in healthcare names lifts sentiment.
- The stock is rebounding from recent softness, tracking sector-wide gains driven by strong earnings and guidance from medical device and clinical research peers.
- The upward move is tied to general industry strength rather than any new company-specific news flow for Hims & Hers Health itself.